Home-based phototherapy for plaque and guttate psoriasis is as effective as office-based phototherapy, results of the ...

Dividend investing can create substantial passive income over time. A conservative example illustrates this potential: ...

The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...

WARN notices filed with the state show more job cuts due in the health sector as companies look to cut costs and streamline ...

By leveraging AI, drug developers are moving beyond incremental gains in efficiency and engaging previously undruggable ...

Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show ...

The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), tracking the healthcare companies under S&P 500, rose 6.27% in ...

A New York federal judge has dismissed a $6.4 billion lawsuit against Bristol-Myers Squibb Co., agreeing with counsel for the ...

From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

IGM Biosciences shifts focus to autoimmune diseases, reduces oncology research, and appoints former Bristol Myers Squibb ...

Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, a new study found.

For the second time in 19 months, a federal judge in New York has dismissed a lawsuit claiming that Bristol Myers Squibb slow ...